Scientists Uncover the “Root Cause” Triggering Early Diabetic Blindness

A key protein, LRG1, was identified as the early cause of diabetic eye damage, and blocking it may stop the disease before ...
Ophthalmology Times

Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
Managed Healthcare Executive

FDA approves Eylea HD for retinal vein occlusion

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Regeneron Wins FDA Nod For Eylea HD With Reduced Injection Schedule For Patients With Vision Loss

FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...
BabyCenter on MSN

Vision changes during pregnancy: How and why it happens

Some vision changes during pregnancy, including blurry vision, double vision, and temporary loss of vision, can be symptoms of preeclampsia or eclampsia. Preeclampsia is a potentially dangerous ...